Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic …

P Corradini, C Tarella, A Olivieri… - Blood, The Journal …, 2002 - ashpublications.org
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic …

P Corradini, C Tarella, A Olivieri, A Gianni, C Voena… - BLOOD, 2002 - iris.unisr.it
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic …

P Corradini, C Tarella, A Olivieri, AM Gianni… - …, 2002 - pubmed.ncbi.nlm.nih.gov
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic …

P Corradini, C Tarella, A Olivieri, A Gianni, C Voena… - BLOOD, 2002 - iris.uniupo.it
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …

[PDF][PDF] Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk …

P Corradini, C Tarella, A Olivieri, AM Gianni, C Voena… - BLOOD, 2002 - Citeseer
High-dose chemoradiotherapy followed by allogeneic hematopoietic stem cell
transplantation (HSCT) is extensively used to treat patients with hematologic malignancies …

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic …

P Corradini, C Tarella, A Olivieri, AM Gianni, C Voena… - Blood, 2002 - research.uniupo.it
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic …

P Corradini, C Tarella, A Olivieri, A Gianni, C Voena… - BLOOD, 2002 - iris.unito.it
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic …

P Corradini, C Tarella, A Olivieri, AM Gianni, C Voena… - Blood, 2002 - europepmc.org
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …

[引用][C] Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk …

P CORRADINI, C TARELLA, F CICERI, F BENEDETTI… - Blood, 2002 - pascal-francis.inist.fr
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce
clinical and molecular remissions in patients with poor-risk hematologic malignancies CNRS …

[HTML][HTML] Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk …

P Corradini, C Tarella, A Olivieri, AM Gianni, C Voena… - Blood, 2002 - Elsevier
A reduced-intensity conditioning regimen was investigated in 45 patients with hematologic
malignancies who were considered poor candidates for conventional myeloablative …